Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Items 301–400 of 630
Kanyi, J., Karwa, R., Pastakia, S. D., Manji, I., Manyara, S. M., & Saina, C. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028016686106 · Cited by 11
Wustrow, I., Ebner, C., Langwieser, N., Haller, B., Luppa, P. B., Bradaric, C., Bongiovanni, D., Stundl, A., Laugwitz, K., Ibrahim, T., et al. (2020) · Platelets · doi:10.1080/09537104.2020.1754380 · Cited by 10
Signorelli, S. S., Conti, G. O., Fiore, M., Elfio, M. G., Cristaldi, A., Nicolosi, I., Zuccarello, P., Zanoli, L., Gaudio, A., Raimondo, D. D., et al. (2020) · Antioxidants · doi:10.3390/antiox9121217 · Cited by 10
Keller, K., Hobohm, L., Münzel, T. F., Lankeit, M., Konstantinides, S., & Ostad, M. A. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.09.002 · Cited by 10
The fibrinolytic system in disease: From molecular pathways to clinical outcomes
Alibrahim, M. N., Sahli, K. A., & Alshehri, F. S. (2025) · Thrombosis Research · doi:10.1016/j.thromres.2025.109504 · Cited by 10
Anticoagulation Management Post Pulmonary Embolism
Naoum, J. J. (2024) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1338 · Cited by 9
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Moodley, O., & Goubran, H. A. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0063-z · Cited by 10
Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients
Coleman, D. M., Andrea, T., & Henke, P. K. (2015) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2015.04.003 · Cited by 9
New insights into treatment of venous thromboembolism
Moll, S. (2014) · Hematology · doi:10.1182/asheducation-2014.1.297 · Cited by 9
Changing paradigms in the management of deep vein thrombosis
Lang, K. J., Saha, P., Roberts, L. N., & Arya, R. (2015) · British Journal of Haematology · doi:10.1111/bjh.13431 · Cited by 9
Angriman, F., Vázquez, F. J., Roy, P., Gal, G. L., Carrier, M., & Gándara, E. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1451-3 · Cited by 9
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients?
Cacciapuoti, F., & Cacciapuoti, F. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211014592 · Cited by 9
Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis
Key, N. S. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0898-8 · Cited by 11
CE: Venous Thromboembolism Updated Management Guidelines
Roberts, S., & Lawrence, S. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000516249.54064.53 · Cited by 11
Anticoagulation is Not Mandatory After Stenting for Malignant Superior Vena Cava Syndrome
Thony, F., Fagedet, D., Michoud, M., Moro‐Sibilot, D., Ferretti, G., & Rodiere, M. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0902-5 · Cited by 9
Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All
Blondon, M., & Bounameaux, H. (2015) · Circulation · doi:10.1161/circulationaha.115.019310 · Cited by 10
Zou, P., Li, H., Cai, J., Li, C., Chen, Z., & Li, X. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1635030 · Cited by 8
Contemporary Treatment of Venous Thromboembolic Disease
Galanis, T., & Merli, G. J. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.09.007 · Cited by 8
Liew, A., & Douketis, J. D. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.770838 · Cited by 8
Maloney, J. P., Branchford, B. R., Brodsky, G. L., Cosmic, M. S., Calabrese, D. W., Aquilante, C. L., Maloney, K. W., González, J. R., Zhang, W., Moreau, K. L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600344r · Cited by 9
Thrombo-prophylaxis in acutely ill medical and critically ill patients
Joshi, R. P., Saigal, S., Sharma, J. P., & Singh, D. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.133902 · Cited by 9
Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study
Vázquez, F. J., Posadas‐Martínez, M. L., de Quirós, F. G. B., & Giunta, D. H. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-200 · Cited by 8
Influence of ADAMTS13 deficiency on venous thrombosis in mice
Tashima, Y., Banno, F., Akiyama, M., & Miyata, T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-08-0656 · Cited by 8
Småbrekke, B., Rinde, L. B., Hald, E. M., Njølstad, I., Mathiesen, E. B., Johnsen, S. H., Hansen, J., Brækkan, S. K., & Lijfering, W. M. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13858 · Cited by 8
The role of bone marrow-derived cells in venous thromboembolism
Campos, J., & Brill, A. G. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105850 · Cited by 8
Thromboembolic characteristics and role of anticoagulation in long-standing Fontan circulation
Westhoff‐Bleck, M., Klages, C. S., Zwadlo, C., Sonnenschein, K., Sieweke, J., Bauersachs, J. K., Bertram, H., & Grosser, U. (2022) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2022.100328 · Cited by 8
Clinical Outcome of Deep Vein Thrombosis Is Related to Thrombophilic Risk Factors
Simon, M., Klaeffling, C., Ward, J., Rauchfuss, S., & Miesbach, W. (2023) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296231152898 · Cited by 8
Xu, D., Xu, R., He, L., Xu, T., Zhang, Z., Han, D., & Du, J. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2016.05.088 · Cited by 8
Medical Management of Pulmonary Embolism: Beyond Anticoagulation
Hsu, N. Y.-H., Wang, T. S., Friedman, O., & Barjaktarević, I. (2017) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2017.07.004 · Cited by 8
Incidental Pulmonary Embolism After Coronary Artery Bypass Surgery: Long-Term Clinical Follow-Up
Beck, K. S., Cho, E. K., Moon, M. H., Kim, D., Song, H., & Jung, J. I. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18186 · Cited by 8
Diagnosis and Anticoagulant Treatment
Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M. M., Fletcher, J. M., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840n · Cited by 8
Self-citationManaging challenging patients with venous thromboembolism: a practical, case-based approach
Douketis, J. D., Ageno, W., Carrier, M., & Kearon, C. (2017) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3879 · Cited by 7
Self-citationBorton, Z. M., Bhangoo, N. S., Quah, C., Stephen, A., & Howard, P. W. (2021) · Hip International · doi:10.1177/1120700021990544 · Cited by 7
Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery
Sobreira, M. L., Marques, M. A., Paschôa, A. F., Ribeiro, A. J. A., Casella, I. B., Burihan, M. C., Matielo, M. F., Soares, R. D. A., de Araújo, W. J. B., Joviliano, E. É., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202301072 · Cited by 8
Carron, M., Tamburini, E., Pettenuzzo, T., Zarantonello, F., Campello, E., Navalesi, P., & Simioni, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-02171-z · Cited by 8
Venous thromboembolism management: where do novel anticoagulants fit?
Spyropoulos, A. C., & Turpie, A. G. G. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.803462 · Cited by 7
Genetics of Coagulation: What the Cardiologist Needs to Know
Anderson, J. A. M., Lim, W., & Weitz, J. I. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.024 · Cited by 8
Hecker, M., Sommer, N., Hecker, A., Bandorski, D., Weigand, M. A., Krombach, G. A., Mayer, E., & WALMRATH, D. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0114-z · Cited by 7
Liu, Z., Tan, J., Deng, Y.-R., Hua, L., & Guo, T. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120414 · Cited by 7
Management of Pulmonary Embolism: State of the Art Treatment and Emerging Research
Esponda, O. L., & Tafur, A. J. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0229-6 · Cited by 8
Update on Pharmacologic Therapy for Pulmonary Embolism
Harikrishnan, P., Palaniswamy, C., & Aronow, W. S. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413506612 · Cited by 9
Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism
Bauersachs, R. M. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.05.022 · Cited by 7
Newman, B. H., Rajpurkar, M., Özgönenel, B., Lal, A., & Kuriakose, P. (2015) · Transfusion · doi:10.1111/trf.13034 · Cited by 7
Effect of Aspirin on Fractalkine in Rats with Pulmonary Embolism
Wang, L.-C., Wu, J.-N., Xia, G.-L., Mao, W. W., Ying, R.-B., Huang, L.-Q., & Jiang, R.-L. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v13i5.15 · Cited by 7
Reaves, A. B., Clarke, C. J., & Tillman, E. M. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r688 · Cited by 7
Extended anticoagulation for unprovoked venous thromboembolism
Castellucci, L. A., de Wit, K., Garcia, D. A., Ortel, T. L., & Gal, G. L. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12121 · Cited by 7
Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies
(GrAM), G. D. A. M., Birocchi, S., Scannella, E., Ferrari, L., & Podda, G. M. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0961-7 · Cited by 8
Pulmonary embolism hotline 2012: Recent and expected trials
Lankeit, M., & Konstantinides, S. (2013) · Hämostaseologie · doi:10.5482/hamo-12-12-0024 · Cited by 6
Difference in fibrinolytic capacity in young patients with venous thrombosis or ischaemic stroke
Skov, J., Sidelmann, J. J., Bladbjerg, E., Jespersen, J., & Gram, J. (2013) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328364c473 · Cited by 6
Critical Review and Update on the Treatment of Acute and Chronic Pulmonary Embolism
Shapiro, N. L., & Bhatt, S. H. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015615901 · Cited by 7
Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients
Zekri-Nechar, K., Barberán, J., Zamorano‐León, J. J., Durbán, M., Andrés-Castillo, A., Cuéllar, C. N., López-Farré, A. J., López‐de‐Andrés, A., Jiménez‐García, R., & Martínez-Martínez, C. H. (2022) · Medicina · doi:10.3390/medicina58111649 · Cited by 6
Aspirin in secondary prevention of recurrent venous thromboembolism
Boonyawat, K., & Crowther, M. A. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1196-4 · Cited by 6
Sista, A. K. (2014) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2014.02.011 · Cited by 6
The Current and Future Landscape of Urinary Thromboxane Testing to Evaluate Atherothrombotic Risk
Neath, S., Jefferies, J. L., Berger, J. S., Wu, A. H. B., McConnell, J. P., Boone, J. L., McCullough, P. A., Jesse, R. L., & Maisel, A. S. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0739 · Cited by 7
Patel, R. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s100299 · Cited by 7
Freed, J. A., & Bauer, K. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00014-5 · Cited by 6
Folkerts, K., Broughton, J., Sheikh, U., & Mckaig, S. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1658589 · Cited by 8
Subtype-Specific Plasma Signatures of Platelet-Related Protein Releasate in Acute Pulmonary Embolism
Baidildinova, G., ten Cate, V., Nagler, M., Panova‐Noeva, M., Rapp, S., Köck, T., Prochaska, J. H., Heitmeier, S., Gerdes, C., Schwers, S., et al. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.10.005 · Cited by 7
Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
Siddiqui, M. A., Jain, C., Usmani, A., Hafeez, A., Khalid, M., & Mujahid, M. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113026 · Cited by 9
The place of new oral anticoagulants in travel medicine
Ringwald, J., Grauer, M., Eckstein, R., & Jelínek, T. (2013) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2013.11.005 · Cited by 8
Lenchus, J. D., Biehl, M., Cabrera, J. L., de Moraes, A. G., & Dezfulian, C. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616648265 · Cited by 6
Die tiefe Venenthrombose: Diagnostik und Therapie
Wustrow, I., & Ibrahim, T. (2016) · CME · doi:10.1007/s11298-016-5549-x · Cited by 6
Orale Antikoagulation mit Vitamin K-Antagonisten – ein Update
Sucker, C., & Litmathe, J. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-017-0577-z · Cited by 7
Siniscalchi, C. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.026 · Cited by 6
Allen, J. I. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2492-x · Cited by 6
Modeling Venous Thrombosis In Vitro: More Than Just (Valve) Pocket Change
Wolberg, A. S. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310919 · Cited by 6
Verlängerte Sekundärprophylaxe nach venöser Thromboembolie
Bauersachs, R. M. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-113679 · Cited by 8
Risque thrombotique des grossesses après un épisode de thrombose veineuse cérébrale
Pourrât, O., Neau, J.-P., Pouget-Abadie, J. F., & Pierre, F. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.08.002 · Cited by 5
Bozkurt, A. K., Akay, H. T., Çalkavur, T., Şırlak, M., Balkanay, O. O., Uğuz, E., Doğancı, S., Polat, A., Bayrak, S., Bozok, Ş., et al. (2021) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2021.22121 · Cited by 6
Bejjani, A., Khairani, C. D., Krishnathasan, D., Rizzo, S. M., Sato, A., Bacare, B., Scimeca, G., Tristani, A., Armero, A., Porio, N. D., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf109 · Cited by 7
Serum Eicosapentaenoic Acid/Arachidonic Acid Ratio Is Low in Patients with Pulmonary Thromboembolism
Oshima, Y., Niki, K., Hiramoto, Y., Morimoto, S., Takami, H. E., & Izumi, M. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.474 · Cited by 5
Duration of Anticoagulation for Venous Thromboembolic Events
Smilowitz, N. R., Mega, J. L., & Berger, J. S. (2014) · Circulation · doi:10.1161/circulationaha.114.010456 · Cited by 6
Aspirin Increases the Risk of Venous Thromboembolism in Surgical Patients
Barmparas, G., Jain, M., Mehrzadi, D., Melo, N., Chung, R., Bloom, M. B., Ley, E. J., & Margulies, D. R. (2014) · The American Surgeon · doi:10.1177/000313481408001002 · Cited by 5
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism
Imberti, D., Pomero, F., Benedetti, R., & Fenoglio, L. M. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1521-8 · Cited by 6
Quelle est la durée du traitement anticoagulant pour une EP/TVP proximale ?
Couturaud, F., Girard, P., Laporte, S., & Sanchez, O. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.05.022 · Cited by 5
Thachil, J. V. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1735453 · Cited by 5
Li, D., Liu, Y., Song, Y. H., & Wen, A. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2026002 · Cited by 5
Hecker, M., Sommer, N., Hecker, A., Bandorski, D., Weigand, M. A., Krombach, G. A., Mayer, E., & WALMRATH, D. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0282-8 · Cited by 5
Rodriguez, M., Dai, W., Lund, H., Osinski, K. I., Zhang, Z., Silverstein, R. L., & Zheng, Z. (2022) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2022.101386 · Cited by 5
Lammers, D. T., Scerbo, M. H., Davidson, A., Pommerening, M. J., Tomasek, J. S., Wade, C. E., Cardenas, J. C., Jansen, J. O., Miller, C. C., & Holcomb, J. B. (2023) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2023-001140 · Cited by 5
Schatoff, D., Jung, I. Y., & Goldberg, I. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.009 · Cited by 5
The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Galanaud, J. ‐., Laroche, J.-P., & Righini, M. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.07.019 · Cited by 5
Abunnaja, S., Clyde, M., Cuviello, A., Brenes, R. A., & Tripodi, G. (2014) · Case Reports in Vascular Medicine · doi:10.1155/2014/174147 · Cited by 5
Thrombophilia diagnosis: a retrospective analysis of a single-center experience
Spychalska-Zwolińska, M., Zwoliński, T., Mieczkowski, A., & Budzyński, J. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000332 · Cited by 6
Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents
Stevens, H., McFadyen, J. D., & Chan, N. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1723953 · Cited by 5
Unprovoked Venous Thromboembolism
Mwansa, H., Zghouzi, M., & Barnes, G. D. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.05.006 · Cited by 5
Use of aspirin for the prevention of lower extremity deep venous thrombosis
Sadaghianloo, N., Jean‐Baptiste, E., Declémy, S., Hassen‐Khodja, R., & Dardik, A. (2014) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2013.10.051 · Cited by 4
Schrör, K., & Rauch, B. H. (2013) · HAL · Cited by 4
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives
Ageno, W., & Donadini, M. P. (2018) · Hämostaseologie · doi:10.1055/s-0038-1641605 · Cited by 4
Self-citationTratamiento de la trombosis venosa profunda de extremidades inferiores
Trujillo‐Santos, J. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2020.05.009 · Cited by 10
Camporese, G., Bernardi, E., Bortoluzzi, C., Noventa, F., Simioni, P., & for the METRO Investigator Study Group (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02896-6 · Cited by 4
del Pozo, M. M., Asenjo, M. M., Franco‐Moreno, A., de Antonio, E. U., & Valle, F. G. (2024) · Revista Clínica Española · doi:10.1016/j.rce.2024.07.007 · Cited by 4
Azam, F., Awaida, C. J., Dogaroiu, A., & Odobescu, A. (2025) · Microsurgery · doi:10.1002/micr.70029 · Cited by 4
Cardi, S., Barco, S., Wolf, S., Rodríguez, P. D., Pérez‐Pinar, M., Skride, A., Tazi, Z. M., López‐Sáez, J. B., Marchena, P. J., Monréal, M., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02706-4 · Cited by 4
Postintervention duration of anticoagulation in venous surgery
ten Cate‐Hoek, A. J., Prins, M. H., Wittens, C. H. A., & Cate, H. T. (2013) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355513476415 · Cited by 4
Platelet–vessel wall interactions and drug effects
Twarock, S., Bagheri, S., Bagheri, S., & Hohlfeld, T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.008 · Cited by 4
Wojtukiewicz, M. Z., Sierko, E., Tomkowski, W. Z., Zawilska, K., Undas, A., Podolak‐Dawidziak, M., Wysocki, P. J., Krzakowski, M. J., Warzocha, K., & Windyga, J. (2016) · Nowotwory Journal of Oncology · doi:10.5603/njo.2016.0062 · Cited by 8
Halámková, J., & Penka, M. (2017) · Klinicka onkologie · doi:10.14735/amko2017100 · Cited by 4
Valasek, A. E., Warren, P. S., & Kumar, R. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27080 · Cited by 4
The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
Eichinger, S., Morange, P., Cattaneo, M., Frétigny, M., Rauch, A., Vlieg, A. V. H., Trégouët, D., Ruf, W., Levi, M. M., Páramo, J. A., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000643 · Cited by 4
Self-citation
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.